Newsroom
March 6th, 2024
August 14th, 2023
June 23, 2023
Access Wire - Bio Conscious Technologies Inc. a leading innovator in healthcare/diabetes technology and applied Artificial Intelligence (AI), has announced a breakthrough in forecasting high-risk diabetic events using CGM data and advanced machine learning (ML) techniques. The Company has published proprietary models on Amazon AWS, making it possible for Endocrinologists, third-party users, scientific organizations, and app developers to help patients with diabetes improve glucose control dynamics.
August 6th, 2021
Forbes - We all get older, but does getting older mean we have to age? The medical field’s approach to manage aging is to address the chronic diseases common to aging, such as heart disease, cognitive decline, type 2 diabetes and hypertension. This whack-a-mole-approach is costly and inefficient.
July 13th, 2021
How one Canadian Start-up is using AI to Improve the Quality of Life in Chronic Disease Patients
Consulate General Of Canada (Boston) - Canadian start-up and CTA Boston alumnus, Bio Conscious, is combining expertise in healthcare and AI to make huge strides in prediction and quality of life for chronic disease patients.
May 26th, 2021
Five Canadian startups making it north of the border with eyes set on the U.S.
Mobilehealth - While the U.S. is often hailed as the capital of innovation, digital health hubs are sprouting up all over the world. To the north, Canadian health tech companies are beginning to emerge.
March 31st, 2021
What Machine Learning Can Teach Us About Glucose Metabolism And Predicting Future Disease
Forbes - When you hear the word "glucose," what do you think of? Diabetes is a serious disease, but it’s skewed our perception of glucose. The health industry has mostly looked at glucose metabolism through a diabetic lens. However, analysis of glucose metabolism with machine learning (ML) shows a more nuanced picture.
February 14th, 2021
Forbes - According to Søren Smed Østergaard, Vice President, Digital Health of Novo Nordisk, the most significant innovations in the diabetes space centered around hardware, artificial intelligence (AI), and data. He believes that having access to more accurate data on individual behavior and medication usage could positively impact ...
September 22nd, 2020
Globe Newswire - Bio Conscious Technologies Inc. (“Bio Conscious”), a Prevention-as-a-Service™ technology company using machine learning to predict and prevent complications from chronic diseases, is announcing that its latest study assessing the capabilities of its Diabits app, has just been published in the JMIR Academic Journal.
August 10th, 2020
Diabetic Patients May Benefit from the Pandemic
Health Tech Insider - Shelter-in-place orders have created their share of problems for everyone, but in some cases, the consequences of the COVID-19 pandemic have had a positive effect. According to an analysis of recent data from Diabits, staying home this spring may have had a positive impact on the lives of diabetes patients.
August 10th, 2020
How Patients with Diabetes are Experiencing Unexpected Benefits from COVID Lockdown
mHealth Times - Diabits patients' average glucose values decreased and daily fluctuations throughout the week became less pronounced during the COVID-19 pandemic.
August 4th, 2020
Data from Diabits Shows Lockdown’s Unexpected Benefit for Diabetes Patients
Yahoo Finance - Following the lockdown in March, Diabits patients average glucose values decreased and daily fluctuations throughout the week became less pronounced.
June 10th, 2020
Study Shows Diabits App can Predict Blood Sugar Values 60-Minutes into the Future
The Journal of mHealth - Bio Conscious has completed an in-house study demonstrating that Diabits is capable of predicting blood glucose levels 60 minutes into the future, an improvement on industry-leading continuous glucose monitoring companies that offer only 20-minute predictions.
June 10th, 2020
AI algorithm predicts glucose levels one hour into the future
Cardio Vascular Business - Bio Conscious, a Vancouver-based healthcare technology company, shared the results of a new in-house study that found Diabits could make accurate predictions using simulated continuous glucose monitoring data. A total of 30 virtual patients were assessed, including some with mixed hypoglycemia awareness and others with impaired hypoglycemia awareness. This virtual cohort also had a mix of adult and pediatric patients.
June 9th, 2020
Diabetes Management App Predicts Blood Sugar Values 60-Minutes into the Future
Techcouver - Vancouver’s Bio Conscious Technologies has completed an in-house study demonstrating that Diabits is capable of predicting blood glucose levels 60 minutes into the future.
June 9th, 2020
New App Predicts Blood Glucose Levels 60 Minutes into the Future
Medical Devices and Diagnostics Industry (MDDI) - Bio Conscious has completed an in-house study demonstrating that its Diabits app is capable of predicting blood glucose levels 60 minutes into the future, an improvement on industry-leading continuous glucose monitoring companies that offer only 20-minute predictions.
June 9th, 2020
Bio Conscious Study Shows Diabits Predicts Blood Sugar Values 60-Minutes Into the Future
BioSpace - Bio Conscious has completed an in-house study demonstrating that its Diabits app is capable of predicting blood glucose levels 60 minutes into the future, an improvement on industry-leading continuous glucose monitoring companies that offer only 20-minute prediction
June 9th, 2020
Bio Conscious Study Shows Diabits Predicts Blood Sugar Values 60-Minutes Into the Future
Markets Insider - Bio Conscious has completed an in-house study demonstrating that its Diabits app is capable of predicting blood glucose levels 60 minutes into the future, an improvement on industry-leading continuous glucose monitoring companies that offer only 20-minute prediction
May 11th, 2020
Bio Conscious Technologies Launches Endobits Smart Patient Management Platform
Bio Conscious launches Endobits, a physician platform that provides decision support for doctors by analyzing real-time patient data to identify and prioritize which patients are in urgent need of care and reduce unnecessary in-person appointments.
April 6th, 2020
Bio Conscious Technologies released the results of Diabits accuracy testing using the FDA-approved Padova T1D Simulator
Bio Conscious Technologies Inc. published the results of the latest in-silico testing of their AI algorithm’s reliability using the FDA approved Padova simulator.
November 14th, 2019
innovateBC News - Diabits is our first product – it’s an app for people with Type 1 diabetes and those with Type 2 diabetes that are on insulin therapy. Diabits learns the user’s blood sugar fluctuations using machine learning and predicts instances of hypo and hyperglycemia (both of which can be life threatening) at least one hour in advance.
April 26th, 2019
Physicians enthusiastic about how AI can help with digital diagnostics
Healthcare IT News - Physicians worldwide have generally positive attitudes towards the use of artificial intelligence in healthcare, according to a new survey of nearly 500 pathologists practicing in 54 countries.
April 24th, 2019
Key Healthcare Stocks To Watch as US Markets Approach Record Highs
Benzinga - Premier Health Group announced that it will be working with Bio Conscious Technologies to pilot an artificial intelligence (AI) powered remote patient monitoring tool. This tool will be integrated into Premier's Juno Electronic Medical Records (EMR) software and patient app.
December 4th, 2018
Healthline - We went ‘back to school’ in November for our first-ever DIABETESMINE UNIVERSITY program held at UC San Francisco Mission Bay.